[1]
K. Pawlaczyk, K. Schwermer, K. Hoppe, and P. Bręborowicz, “Atorvastatin as a first choice drug in patients with impaired renal function”, J EBM, vol. 8, no. 4(29), pp. 50-53, Dec. 2015.